Articles related to PHARMACOLOGY REVIEW

The Evolution of AREDS

AREDS2 remains the evidence-based standard for AMD supplementation, but expanding understanding of complement dysregulation, mitochondrial dysfunction, and macular carotenoid biology has prompted discussion about whether a next-generation formulation could address pathways the current one does not target.

Ophthalmology June 29th 2026

Tags: AMD/MACULAR DEGENERATION EVIDENCE REVIEW GEOGRAPHIC ATROPHY PHARMACOLOGY REVIEW RETINA VISION LOSS VITAMINS/SUPPLEMENTS

Conexiant

Early Infant Antacid Use Linked to Celiac

Test-negative case-control design controlled for healthcare-seeking behavior, suggesting cohort associations reflected confounding rather than causal mechanisms.

Allergy & Immunology June 4th 2025

Tags: CELIAC DISEASE CORRELATIONS/LINKS PEDIATRIC GASTROENTEROLOGY PHARMACOLOGY REVIEW

News Medical

Potential Health Benefits of Methylene Blue

Methylene blue’s ability to penetrate the blood-brain barrier while reducing oxidative stress and promoting Nrf2 expression presents a novel therapeutic pathway for neurodegenerative disorders that warrants further investigation despite limited clinical evidence.

Emergency Medicine April 30th 2025

Tags: CRITICAL CARE EMERGING THERAPIES PHARMACOLOGY REVIEW

Trending Topics:

Articles related to PHARMACOLOGY REVIEW

The Evolution of AREDS

Early Infant Antacid Use Linked to Celiac

Potential Health Benefits of Methylene Blue

Topics

Sources

The Healthcare Communications Network is owned and operated by IQVIA Inc. Click below to leave this site and continue to IQVIA’s Privacy Choices form

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form